Production (Stage)
Nexien BioPharma, Inc.
NXEN
$0.0145
$0.00552.63%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -17.82% | -50.00% | -72.38% | -88.03% | -81.37% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | 5.00% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -41.96% | -50.00% | -77.38% | -90.26% | -75.43% |
|
|
|||||
| Total Current Assets | -41.96% | -50.00% | -77.38% | -90.26% | -75.43% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -41.96% | -50.00% | -77.38% | -90.26% | -75.43% |
|
|
|||||
| Total Accounts Payable | 87.42% | 100.55% | 90.00% | 125.42% | 98.66% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | 27.25% | 25.13% | 18.56% | 15.03% | 10.86% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 35.10% | 33.84% | 26.78% | 23.82% | 17.71% |
|
|
|||||
| Total Current Liabilities | 35.10% | 33.84% | 26.78% | 23.82% | 17.71% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 27.25% | 25.13% | 18.56% | 15.03% | 10.86% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 35.10% | 33.84% | 26.78% | 23.82% | 17.71% |
|
|
|||||
| Common Stock & APIC | 0.56% | 0.93% | 1.18% | 1.64% | 1.85% |
| Retained Earnings | -1.64% | -1.85% | -1.73% | -2.12% | -2.20% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -38.49% | -34.53% | -34.73% | -43.33% | -41.25% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -38.49% | -34.53% | -34.73% | -43.33% | -41.25% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -38.49% | -34.53% | -34.73% | -43.33% | -41.25% |
|
|
|||||